コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 R order with their physician, family, and/or attorney.
2 atus, alcohol use, and the involvement of an attorney.
3 had a living will and/or a medical power of attorney.
4 were more likely to have a durable power of attorney (34% v 8%, P =.01) and were more likely to have
5 te in research and assign a durable power of attorney (96% scored 2 or less on the Clinical Dementia
8 ad discussed a living will, medical power of attorney, and/or DNR order with their physician, family,
9 by letting administrative law judges, patent attorneys, and a scientific majority decide these cases.
10 e can better communicate with risk managers, attorneys, and insurers; and finally, so that we can bet
16 , biotech, and food industry leaders; patent attorneys; economists; public and private provider group
17 l genetics have attracted legal interest, as attorneys explore their use in criminal and civil cases.
18 n of (1) living wills, (2) durable powers of attorney for health care (DPAHC), (3) patient-physician
19 panding the legal scope of durable powers of attorney for health care may have a significant impact.
20 Subjects who had assigned a durable power of attorney for health care were less likely to die in a ho
21 defined as having a living will, a power of attorney for health care, or life-support instructions.
25 e negotiation with the Office of the Vermont Attorney General and manual photocopying of individual d
28 n agreement signed in 1998 between the state attorneys general and tobacco companies, ended payments
30 (FDA), Federal Trade Commission (FTC), state attorneys general, and US Department of Justice; and sea
33 linchpin is assignment of a durable power of attorney in the early-to-moderate stage of Alzheimer's d
34 observer reliability between the two raters (attorneys) in interpretation of six items characterizing
35 us, mental health status, health habits, and attorney involvement prior to performing carpal tunnel r
36 ourt records, we found that assignment to an attorney made a large difference in whether participants
37 ng a living will, 46% had a medical power of attorney (n = 98), and 19% had a do-not-resuscitate (DNR
39 ans, epidemiologists, patient advocates, and attorneys participated in the workshop, which was conven
40 omes of a group of 16 742 donors of power of attorney (PoA) registrations with a "loss of financial c
41 will, and health care proxy/durable power of attorney), positive religious coping remained a signific
44 recorded between 2019 and 2023 for which the attorney reported that the donor lost financial capacity
45 s made by the Harris County, Texas, District Attorney's office from January 2007 to December 2018.
47 he holder of the deceased's durable power of attorney, whereas only 7 (11%) reported they were likely
48 surrogate consent through a durable power of attorney would become necessary to facilitate continued